Center-Authored Papers

Filters: Author is Mark, Karen E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Mark KE, Spruance S, Kinghorn GR, Sacks SL, Slade HB, Meng T-C, Selke S, Magaret A, Wald A.  2014.  Three Phase III Randomized Controlled Trials of Topical Resiquimod 0.01% Gel to Reduce Anogenital Herpes Recurrences.. Antimicrobial agents and chemotherapy. Abstract
R
Mark KE, Wald A, Magaret AS, Selke S, Kuntz S, Huang M-L, Corey L.  2010.  Rapidly cleared episodes of oral and anogenital herpes simplex virus shedding in HIV-infected adults.. Journal of acquired immune deficiency syndromes (1999). 54(5):482-8. Abstract
Mark KE, Wald A, Magaret AS, Selke S, Olin L, Huang M-L, Corey L.  2008.  Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.. The Journal of infectious diseases. 198(8):1141-9. Abstract
Schiffer JT, Swan D, Al Sallaq R, Magaret A, Johnston C, Mark KE, Selke S, Ocbamichael N, Kuntz S, Zhu J et al..  2013.  Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract.. eLife. 2:e00288. Abstract
P
Moss NJ, Magaret A, Laing KJ, Kask AS, Wang M, Mark KE, Schiffer JT, Wald A, Koelle DM.  2012.  Peripheral blood CD4 T-cell and pDC reactivity to HSV-2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes.. Journal of virology. 86(18):9952-63. Abstract
M
Schiffer JT, Abu-Raddad L, Mark KE, Zhu J, Selke S, Koelle DM, Wald A, Corey L.  2010.  Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes.. Proceedings of the National Academy of Sciences of the United States of America. 107(44):18973-8. Abstract
I
Mark KE, Wald A, Drolette L, Golden MR.  2008.  Internet and email use among STD clinic patients.. Sexually transmitted diseases. 35(11):960-5. Abstract
Barnabas RV, Wasserheit JN, Huang Y, Janes H, Morrow RA, Fuchs J, Mark KE, Casapia M, Mehrotra DV, Buchbinder SP et al..  2011.  Impact of Herpes Simplex Virus Type 2 on HIV-1 Acquisition and Progression in an HIV Vaccine Trial (the Step Study).. Journal of acquired immune deficiency syndromes (1999). 57(3):238-244. Abstract
F
Schiffer JT, Abu-Raddad L, Mark KE, Zhu J, Selke S, Magaret AS, Wald A, Corey L.  2009.  Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model.. Science translational medicine. 1(7):7ra16. Abstract